Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2011, Article ID 673752, 13 pages
Research Article

Recovery and Biodistribution of Ex Vivo Expanded Human Erythroblasts Injected into NOD/SCID/IL2R 𝜸 n u l l mice

1The Tisch Cancer Institute and Myeloproliferative Disease Research Consortium (MPD-RC), Mount Sinai School of Medicine, One Gustave L. Levy Place, P.O. Box 1079, New York, NY 10029, USA
2Center for Cell Engineering, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA
3Cell Biology and Neuroscience, Istituto Superiore di Sanità, 00161 Rome, Italy
4Hematology, Oncology, and Molecular Medicine, Istituto Superiore di Sanità, 00161 Rome, Italy

Received 1 May 2011; Accepted 6 June 2011

Academic Editor: Giuliano Grazzini

Copyright © 2011 Barbara Ghinassi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Supplementary Material

The supplemental material contains details on the experimental design of the transfusion of CFSE-labeled (Supplemental Figure 1) and ExtLuc+ (Supplemental Figure 2) human erythroblasts into NOD/SCID/IL2Rnull mice as well as the gating of CD36/CD235a labeling used to classify the maturity of human erythroblasts by flow cytometry (Supplemental Figure 3) and the analyses of the levels of CD184, CD162 and CD49d expressed by human erythroblasts generated ex vivo from adult blood and cord blood according to their maturation stage (defined by CD235a expression, Supplemental Figure 4).

  1. Supplementary Figure 1
  2. Supplementary Figure 2
  3. Supplementary Figure 3
  4. Supplementary Figure 4